
YahooFinanceBusiness
The projected fair value for Moderna is US$151 based on 2 Stage Free Cash Flow to Equity Current share price of US$79.01 suggests Moderna is potentially 48% undervalued Analyst price target for MRNA is US$140 which is 7.6% below our fair value estimate Does the November share price for Moderna,